Casper Joseph Michael
Transaction: 01/27/2026
OTHER
Change
+100,000
Price
$2.39
Filing
02/17/2026
Type
OTHER
NRx Pharmaceuticals, Inc.
NRXP • Biotechnology
$3.49
▲ +0.06 (+1.75%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$131.40M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.31Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:14 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.49
Change1.75%
Shares Out37.65M
Market Cap$131.40M
Enterprise Value$105.54M
52W Range1.62 - 5.05
Beta2.18
P/E-5.60
P/S38.71
P/B-772.92
P/FCF-6.36
EV/Sales31.10
Price$3.49
Change1.75%
Shares Out37.65M
Market Cap$131.40M
Enterprise Value$105.54M
52W Range1.62 - 5.05
Beta2.18
P/E-5.60
P/S38.71
P/B-772.92
P/FCF-6.36
EV/Sales31.10
EV/EBITDA-5.39
EV/FCF-5.11
Earnings Yield-17.87%
FCF Yield-15.73%
Dividend Yield0.00%
Gross Margin58.78%
Oper. Margin-13.24%
Profit Margin-23.36%
Debt/Eq-0.04
Current Ratio0.31
Quick Ratio0.31
Target$2.00
Target Upside-42.69%
Target Median$2.00
Target Range2.00 - 2.00
Volume903.27K
Avg Volume1.25M
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
27
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Weak liquidity · 0.31Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
100/100
Bullish
Bullish
5
Hold
0
Bearish
0
Price Target
2026-08-19
Low
$2.00
Mean
$2.00
Median
$2.00
High
$2.00
Insider Transactions
Recent executive and insider activity
Casper Joseph Michael
Transaction: 01/27/2026
BUY
Change
+100,000
Price
$2.39
Filing
02/17/2026
Type
BUY
Flynn Patrick John
Transaction: 04/09/2025
BUY
Change
+50,000
Price
$1.73
Filing
09/10/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Casper Joseph Michael | OTHER | +100,000 | $2.39 | 01/27/2026 | 02/17/2026 |
| Casper Joseph Michael | BUY | +100,000 | $2.39 | 01/27/2026 | 02/17/2026 |
| Flynn Patrick John | BUY | +50,000 | $1.73 | 04/09/2025 | 09/10/2025 |
| Hurvitz Chaim | BUY | +25,000 | $1.73 | 04/09/2025 | 09/10/2025 |
| McBride Dennis | BUY | +25,000 | $1.73 | 04/09/2025 | 09/10/2025 |
| Javitt Jonathan C | BUY | +125,000 | $1.73 | 04/09/2025 | 09/10/2025 |
| B Group, Inc. | OTHER | 0 | Not reported | 08/18/2025 | 08/21/2025 |
| ABRAMS MICHAEL S | BUY | +50,000 | $2.94 | 02/07/2025 | 02/11/2025 |
| Javitt Jonathan C | BUY | +40,000 | $1.17 | 12/17/2024 | 12/18/2024 |
| ABRAMS MICHAEL S | OTHER | 0 | Not reported | 11/18/2024 | 11/22/2024 |
| McBride Dennis | SELL | -6,320 | $15.30 | 06/13/2024 | 06/26/2024 |
| Rehnquist Janet | OTHER | 0 | Not reported | 12/28/2023 | 01/16/2024 |
| Narido Richard Clavano | OTHER | 0 | Not reported | 09/13/2023 | 09/19/2023 |
| Hurvitz Chaim | BUY | +70,000 | $0.29 | 08/30/2023 | 09/11/2023 |
| Gorovitz Aaron | BUY | +35,000 | $0.32 | 08/30/2023 | 09/11/2023 |
| Javitt Jonathan C | BUY | +100,000 | $0.33 | 08/23/2023 | 08/24/2023 |
| Javitt Jonathan C | BUY | +200,000 | $0.32 | 08/22/2023 | 08/23/2023 |
| Javitt Jonathan C | OTHER | 0 | Not reported | 12/31/2022 | 02/14/2023 |
| VAN VOORHEES SETH | BUY | +30,000 | $1.10 | 12/16/2022 | 12/19/2022 |
| Willard Stephen H | BUY | +50,000 | $1.17 | 12/16/2022 | 12/19/2022 |